Aranjuez

Researchers are collecting detailed information about patients with venous thromboembolism (VTE), which includes blood clots in veins such as deep-vein thrombosis and pulmonary embolism. The project aims to improve doctors' understanding of VTE, especially in patients often excluded from clinical trials, like pregnant women, elderly individuals, cancer patients, and those with other complex health issues. The goal is to reduce deaths, clot recurrence, bleeding problems, and artery-related events by sharing this knowledge widely. The study involves gathering extensive data on each patient's health status, treatments, and outcomes during the first three months of therapy. This registry is available online to help doctors quickly find information on patients with similar medical profiles and make informed decisions about managing high-risk individuals. There are no specific interventions being tested; instead, the focus is on collecting real-world patient data. Participants provide informed consent and are followed for at least three years to monitor for new clot events and complications. Researchers track recurrences of VTE, bleeding episodes, and deaths, aiming to create tools that predict which patients are most at risk for problems. This ongoing data collection supports improving care and guiding treatment decisions for diverse patient groups over time.

Researchers are evaluating how well women with postmenopausal osteoporosis stick to their combined treatment of oral bisphosphonates along with daily calcium and vitamin D supplements. This is an observational, cross-sectional, and multicenter study focused on understanding patient adherence to these common therapies for managing osteoporosis after menopause. The study involves collecting information during a single visit aligned with the patient's usual follow-up care. During this one-time visit, data will be gathered from the patient's medical history and through an interview using three questionnaires. These questionnaires assess how the patient takes their treatment, including frequency, any forgetfulness, and satisfaction with their current treatment plan. The treatment regimens under study involve bisphosphonates taken orally on a weekly or monthly basis, combined with daily calcium and vitamin D supplements in sachet or chewable tablet form. Participants will provide information about their medication habits during the visit, which coincides with routine clinical care. Researchers will measure adherence to the combined treatment as the primary outcome. Since the study involves only a single visit, it minimizes participant burden while providing insight into real-world treatment adherence in women with postmenopausal osteoporosis.